Five-Year, Government Funded, Epidemiology Study Confirms Safety of Aspartame
A five year epidemiology study by the United States National Cancer Institute
confirms previous study conclusions that there is no link between aspartame
consumption and leukemias, lymphomas and brain tumours. The study, presented at
the American Association of Cancer Research meeting in Washington, D.C. on the 4
April, 2006 evaluated over 500,000 men and women between the ages of 50 and 69
over a five-year period. The researchers found that there was no evidence of an
increased risk of leukemias, lymphomas and brain tumours among people who use
aspartame. The researchers report, "Our findings from this epidemiologic study
suggest that consumption of aspartame-containing beverages does not raise the
risk of hematopoietic or brain malignancies."
The study confirms the findings of a recent 2005 report, Review of Lymphatic
and Hematopoietic Cancer Incidence Trends & Consumption of Aspartame, in
which researchers concluded, upon examining cancer trends from the National
Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program
that there is no consistent pattern (of leukemias or lymphomas) that parallels
the rise in aspartame consumption. Further, the findings also support those of
three recent animal studies conducted by the National Toxicology Program (NTP)
designed to evaluate whether aspartame is capable of causing cancer. These U.S.
government funded and managed studies were conducted using Good Laboratory
Practices (GLP). The results of these cancer studies, in which aspartame was fed
to mice bred to be especially sensitive to cancer-causing agents, unequivocally
indicated that "there was no evidence of carcinogenic activity of aspartame."